Skip to content

13F-HR filed by New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 20 holding rows worth $359,521,000 by the sum of the rows.

Accession
0000950123-19-004959
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 20 entries on the cover page, a total value of $339,085,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $359,521,000 with VALUE read as thousands by filing date, 13F file number 028-16681. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The cover page states a total of $339,085,000, 6% less than the sum of the rows, $359,521,000. This page uses the sum of the rows.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DECIPHERA PHARMACEUTICALS IN24344T101COM4,104,140$95,257,000thousands by filing date
PRINCIPIA BIOPHARMA INC74257L108COM2,625,713$89,274,000thousands by filing date
ARVINAS INC04335A105COM2,283,048$33,698,000thousands by filing date
NEURONETICS INC64131A105COM1,543,115$23,532,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM2,245,221$21,262,000thousands by filing date
ALECTOR INC014442107COMMON STOCK787,769$14,747,000thousands by filing date
APTINYX INC03836N103COM3,533,424$14,310,000thousands by filing date
ITERUM THERAPEUTICS PLC SHS NEWG6333L101Stock1,456,303$11,536,000thousands by filing date
ObsEva SAH5861P103COM900,501$11,517,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM5,020,446$8,585,000thousands by filing date
COGENT BIOSCIENCES INC COM903214104COM1,795,545$7,882,000thousands by filing date
VERSARTIS INC92529L102COM970,659$6,833,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock215,550$4,753,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock167,700$3,817,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock423,300$3,327,000thousands by filing date
AFFIMED N VN01045108COM732,774$3,078,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,350,000$2,835,000thousands by filing date
CHIASMA INC16706W102COM400,000$2,080,000thousands by filing date
PDS BIOTECHNOLOGY CORP10465T107COM117,242$868,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM402,118$330,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-19-004959this filing2019-05-15acceptance time not in the bulk data set
13F-HR/A 0000950123-19-005820 base2019-06-04acceptance time not in the bulk data set